Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER vs Olanzapine Safety in Schizophrenia
ChiCTR-IPR-16009208Phase 4Recruiting
- Sponsor
- The Seventh People's Hospital of Shaoxing City
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in schizophrenia comparing Paliperidone Extended-Release Tablets with Olanzapine (2 arms). Primary endpoints: alanine aminotransferase (ALT), aspartate aminotransferase (AST) and 2 more. Started Jun 2016; status: recruiting.
02
Drugs
paliperidoneolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-IPR-16009208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009208.